COHR
Coherent Corp
$169.76-12.98%
Setup
No setup
Buy Zone
$173.76-$182.45
Sector
Scientific & Technical Instruments
Industry
Scientific & Technical Instruments
71
Recommendation
No setup
Hold
No active chart path confirmed. Keep on watchlist until price, volume, and setup align.
COHR chart
Loading chart…
ADX
Weak or Absent19.7Long Term
Range →Intermediate Term
Range →Short Term
Down ↓Overall Quality71
RS Rating
68
relative strength
Fundamentals
82
Strong fund-Q
Volume Demand
68
+137% vs avg
Technical Setup
25
2/8 checks
Industry/Theme
91
Scientific & Technical Instruments
Trade Plan
No setup
Entry
$173.76
Entry Zone
$173.76-$182.45
Stop / Risk
$159.86
RS Rating
68
Volume confirmed
No
Targets
$208.51 / $217.2
Breakout · IBD Setup
1 ✓ 7 ✗
Entry $173.76–$182.45Stop $159.86Target $208.51 / $217.2
Market regimeRange
Quality71
RS Rating68
Above 50-MA-37.6%
Above 200-MA-42.74%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
71
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q82 · Strong
StatusHold
Stock Data
52-Week Range126 – 440
Price % Chg YTD-8.02%
Price % Chg 4wk-49.26%
50-Day Avg Vol7.3 Mil
P/E Ratio51.1
Market Cap$41B
SectorTechnology
IndustryScientific & Technical Instruments
Company Fundamentals
EPS % Chg (Qtr)243.6%
Sales % Chg (Qtr)33.75%
EPS Growth 5y11.7%
Sales Growth 5y18.04%
Annual ROE8.46%
Gross Margin38.38%
Operating Margin13.79%
Net Margin10.82%
Debt / Equity0.33
Setup levels
Current price
$169.76
Pivot
$173.76
Distance to buy
-61.4%
52-week range
126-440.02
Trigger evidence
No active trigger evidence available.
Financial health checks
4/5
Return on equity above 15%
ROE 8.46%
Net margin above 10%
Net margin 10.82%
EPS growing quarter on quarter
EPS q/q 243.6%
Sales growing quarter on quarter
Sales q/q 33.75%
Debt to equity below 1.0
D/E 0.33
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE8.46%
vs sector -4.9%
Net margin10.82%
vs sector -0.8%
Gross margin38.38%
vs sector -27.6%
EPS growth q/q243.6%
vs sector +185.9%
Sales growth q/q33.75%
vs sector +4.1%
Debt / equity0.33
vs sector +0.03
Business quality
82
GradeStrong
EPS rating89
P/E51.1
Market cap$41B
IndustryScientific & Technical Instruments
Technical checks
Über 50-MA
Fail
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-04
Trigger date
—
Days on list
2
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.